Table 2.
Study population demographics
| Variable | Value | Total Population n = 502; n (%) |
Adherent n = 206; n (%) |
Non-Adherent n = 296; n (%) |
P Value |
|---|---|---|---|---|---|
| Age, years | < 49 | 245 (48.8) | 100 (48.5) | 145 (49.0) | .59 |
| ≥ 49 | 257 (51.2) | 106 (51.5) | 151 (51.0) | ||
| Sex/gender | Female | 112 (22.3) | 50 (24.3) | 62 (20.9) | .37 |
| Male | 381 (75.9) | 154 (74.8) | 227 (76.7) | ||
| Transgender MTF | 9 (1.8) | 2 (1.0) | 7 (2.4) | ||
| Race/ethnicity | White | 268 (53.4) | 105 (51.0) | 163 (55.1) | <.01a |
| Hispanic/Latino | 70 (13.9) | 32 (15.5) | 38 (12.8) | ||
| Black/African American | 143 (28.5) | 52 (25.2) | 91 (30.7) | ||
| American Indian/Alaskan Native | 4 (0.8) | 2 (1.0) | 2 (0.7) | ||
| Asian | 17 (3.4) | 15 (7.3) | 2 (0.7) | ||
| MSM statusb | Non-MSM | 231 (46.0) | 110 (53.4) | 121 (40.9) | .01 |
| MSM | 271 (54.0) | 96 (46.4) | 175 (59.1) | ||
| Distance from clinic, miles | < 15 | 402 (80.1) | 171 (83.0) | 231 (78.0) | .30 |
| 15–70 | 62 (12.4) | 20 (9.7) | 42 (14.2) | ||
| > 70 | 38 (7.6) | 15 (7.3) | 23 (7.8) | ||
| Number of clinic visits/year | < 3 | 255 (50.8) | 105 (51.0) | 150 (50.7) | .95 |
| ≥ 3 | 247 (49.2) | 101 (49.0) | 146 (49.3) | ||
| Percentage of missed clinic appointments | ≤ 10% | 264 (52.6) | 131 (63.6) | 133 (44.9) | <.01 |
| > 10% | 238 (47.4) | 75 (36.4) | 163 (55.1) | ||
| Employment status | Unemployed | 174 (34.7) | 63 (30.6) | 111 (37.5) | .11 |
| Employed/Retired | 328 (65.3) | 143 (69.4) | 185 (62.5) | ||
| Insurance status and assistance programs | Uninsured | 37 (7.4) | 17 (8.3) | 20 (6.8) | .25 |
| Ever received Medicare/Medicaid | 173 (34.5) | 61 (29.6) | 112 (37.8) | ||
| Ryan White/ADAP | 204 (40.6) | 87 (42.2) | 117 (39.5) | ||
| Private Insurance Only | 88 (17.5) | 41 (19.9) | 47 (15.9) | ||
| Primary care clinic | UNMC HIV Clinic | 152 (30.3) | 63 (30.6) | 89 (30.1) | .61 |
| Other UNMC Clinic | 112 (22.3) | 50 (24.3) | 62 (20.9) | ||
| Non-UNMC Clinic | 238 (47.4) | 93 (45.1) | 145 (49.0) | ||
| Most recent CD4 count, cells/mm3 | > 200 | 471 (93.8) | 204 (99.0) | 267 (90.2) | <.01 |
| ≤ 200 | 31 (6.2) | 2 (1.0) | 29 (9.8) | ||
| Most recent HIV RNA level, copies/mL | ≤ 50 | 437 (87.1) | 187 (90.8) | 250 (84.5) | .04 |
| > 50 | 65 (12.9) | 19 (9.2) | 46 (15.5) |
Data are presented as n (%). P-values are based on univariate analysis.
Abbreviations: Transgender MTF = Transgender Male to Female; MSM = Men who have sex with men
aP-value indicates a higher percentage of Asian population in the Adherent cohort.
bMSM was used to delineate eligibility for vaccination with HepA as defined in the 2018 CDC Immunization Guidelines.